Have a feature idea you'd love to see implemented?
Let us know!
OMER Omeros Corp
Price (delayed)
$3.81
Market cap
$220.78M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.35
Enterprise value
$663.01M
Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous
Highlights
The debt has declined by 6% since the previous quarter and by 4.9% year-on-year
Omeros's quick ratio has decreased by 30% from the previous quarter but it has increased by 14% YoY
OMER's equity has dropped by 75% since the previous quarter
The EPS has declined by 19% since the previous quarter
Key stats
What are the main financial stats of OMER
Market
Valuations
Earnings
Shares outstanding
57.95M
Market cap
$220.78M
Enterprise value
$663.01M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$107.62M
EBITDA
-$106.8M
Free cash flow
-$155.53M
Per share
Balance sheet
Liquidity
EPS
-$2.35
Free cash flow per share
-$2.68
Book value per share
-$2.15
Revenue per share
$0
TBVPS
$6.15
Total assets
$356.31M
Total liabilities
$480.91M
Debt
$444.36M
Equity
-$124.6M
Working capital
$143.46M
Debt to equity
-3.57
Current ratio
3.41
Quick ratio
2.81
Net debt/EBITDA
-4.14
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-33.6%
Return on equity
N/A
Return on invested capital
-14.1%
Return on capital employed
-36.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OMER stock price
How has the Omeros stock price performed over time
Intraday
-0.52%
1 week
0.53%
1 month
4.67%
1 year
37.05%
YTD
16.51%
QTD
-4.03%
Financial performance
How have Omeros's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$186.11M
Net income
-$140.04M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 15% from the previous quarter
Omeros's operating income has decreased by 11% YoY and by 11% from the previous quarter
Growth
What is Omeros's growth rate over time
Valuation
What is Omeros stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 19% since the previous quarter
OMER's equity has dropped by 75% since the previous quarter
Efficiency
How efficient is Omeros business performance
The ROA has contracted by 27% from the previous quarter
Omeros's ROIC has decreased by 24% from the previous quarter
Dividends
What is OMER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OMER.
Financial health
How did Omeros financials performed over time
The total assets is 26% less than the total liabilities
The total assets has contracted by 32% YoY and by 19% from the previous quarter
Omeros's quick ratio has decreased by 30% from the previous quarter but it has increased by 14% YoY
Omeros's debt to equity has plunged by 116% YoY but it has increased by 46% from the previous quarter
OMER's equity has dropped by 75% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.